NASDAQ:VRML - Vermillion Stock Price, Price Target & More

$1.17 +0.02 (+1.74 %)
(As of 04/20/2018 12:36 PM ET)
Previous Close$1.15
Today's Range$1.10 - $1.20
52-Week Range$0.88 - $2.10
Volume56,377 shs
Average Volume77,290 shs
Market Capitalization$82.65 million
P/E RatioN/A
Dividend YieldN/A
Beta2.15

About Vermillion (NASDAQ:VRML)

Vermillion logoVermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance outcomes for women in the United States. It is developing novel diagnostic tests for gynecologic disease with focus on ovarian cancer. The company's products include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor. It serves clinical reference laboratories, hospital laboratories, and physician offices. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.

Receive VRML News and Ratings via Email

Sign-up to receive the latest news and ratings for VRML and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:VRML
CUSIPN/A
Phone512-519-0400

Debt

Debt-to-Equity Ratio0.44%
Current Ratio2.42%
Quick Ratio2.38%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$3.12 million
Price / Sales26.27
Cash FlowN/A
Price / CashN/A
Book Value$0.06 per share
Price / Book19.50

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-10,490,000.00
Net Margins-336.33%
Return on Equity-206.13%
Return on Assets-117.38%

Miscellaneous

Employees40
Outstanding Shares70,040,000

How to Become a New Pot Stock Millionaire

Vermillion (NASDAQ:VRML) Frequently Asked Questions

What is Vermillion's stock symbol?

Vermillion trades on the NASDAQ under the ticker symbol "VRML."

How were Vermillion's earnings last quarter?

Vermillion, Inc. (NASDAQ:VRML) released its quarterly earnings results on Tuesday, March, 13th. The company reported ($0.05) EPS for the quarter. The business had revenue of $0.80 million for the quarter. Vermillion had a negative net margin of 336.33% and a negative return on equity of 206.13%. View Vermillion's Earnings History.

What price target have analysts set for VRML?

1 brokerages have issued 12 month price objectives for Vermillion's shares. Their predictions range from $2.25 to $2.25. On average, they anticipate Vermillion's stock price to reach $2.25 in the next twelve months. View Analyst Ratings for Vermillion.

Who are some of Vermillion's key competitors?

Who are Vermillion's key executives?

Vermillion's management team includes the folowing people:
  • Ms. Valerie Barber Palmieri, Chief Exec. Officer, Pres and Director (Age 57)
  • Mr. Fred Ferrara, Chief Operating Officer (Age 50)
  • Mr. Robert Harry Beechey, Chief Financial Officer
  • Dr. Marra Francis M.D., Chief Medical Officer
  • Mr. Patrick Carpenter, Gen. Mang. of ASPiRA LABS

Has Vermillion been receiving favorable news coverage?

Media coverage about VRML stock has trended somewhat positive this week, Accern reports. The research group scores the sentiment of media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Vermillion earned a media sentiment score of 0.06 on Accern's scale. They also assigned news headlines about the company an impact score of 47.06 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

How do I buy shares of Vermillion?

Shares of VRML can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Vermillion's stock price today?

One share of VRML stock can currently be purchased for approximately $1.17.

How big of a company is Vermillion?

Vermillion has a market capitalization of $82.65 million and generates $3.12 million in revenue each year. Vermillion employs 40 workers across the globe.

How can I contact Vermillion?

Vermillion's mailing address is 12117 BEE CAVES ROAD BUILDING THREE SUITE 100, AUSTIN TX, 78738. The company can be reached via phone at 512-519-0400 or via email at [email protected]


MarketBeat Community Rating for Vermillion (VRML)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  115 (Vote Outperform)
Underperform Votes:  85 (Vote Underperform)
Total Votes:  200
MarketBeat's community ratings are surveys of what our community members think about Vermillion and other stocks. Vote "Outperform" if you believe VRML will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VRML will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Vermillion (NASDAQ:VRML) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Vermillion in the last 12 months. Their average twelve-month price target is $2.25, suggesting that the stock has a possible upside of 92.31%. The high price target for VRML is $2.25 and the low price target for VRML is $2.25. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.25$2.25$2.25$1.75
Price Target Upside: 92.31% upside53.12% upside53.12% upside32.58% upside

Vermillion (NASDAQ:VRML) Consensus Price Target History

Price Target History for Vermillion (NASDAQ:VRML)

Vermillion (NASDAQ:VRML) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/2/2017Canaccord GenuityBoost Price TargetBuy$1.75 -> $2.25N/AView Rating Details
(Data available from 4/20/2016 forward)

Earnings

Vermillion (NASDAQ:VRML) Earnings History and Estimates Chart

Earnings by Quarter for Vermillion (NASDAQ:VRML)

Vermillion (NASDAQ VRML) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/13/2018Q4 2017($0.05)$0.80 millionViewN/AView Earnings Details
11/8/2017Q3 2017($0.04)($0.06)$0.70 millionViewN/AView Earnings Details
8/9/2017Q2 2017($0.04)($0.04)$0.90 millionViewListenView Earnings Details
5/18/2017Q1 2017($0.04)($0.05)$0.73 millionViewN/AView Earnings Details
3/29/2017Q4 2016($0.05)$0.81 millionViewN/AView Earnings Details
11/10/2016Q316($0.06)($0.07)$0.62 millionViewN/AView Earnings Details
8/10/2016Q216($0.09)($0.07)$0.71 millionViewListenView Earnings Details
5/16/2016Q116($0.09)($0.09)$0.51 millionViewListenView Earnings Details
3/24/2016Q415($0.10)$1.20 million$0.36 millionViewListenView Earnings Details
11/12/2015Q315($0.10)($0.10)$0.57 million$0.33 millionViewListenView Earnings Details
8/13/2015Q215($0.08)($0.11)$1.50 million$535.00 millionViewListenView Earnings Details
5/11/2015Q115($0.10)($0.10)$0.81 million$0.95 millionViewListenView Earnings Details
3/25/2015Q414($0.08)($0.11)$1.59 million$1.57 millionViewListenView Earnings Details
11/13/2014Q3 2014($0.16)$0.32 millionViewN/AView Earnings Details
8/14/2014Q2 2014($0.15)$0.32 millionViewN/AView Earnings Details
5/15/2014Q1 2014($0.11)$0.31 millionViewN/AView Earnings Details
3/6/2014Q4 2013($0.07)$1.59 millionViewN/AView Earnings Details
11/14/2013Q3($0.10)$319.00 million$330.00 millionViewListenView Earnings Details
8/14/2013Q2 2013($0.11)$0.3210 million$0.2320 millionViewListenView Earnings Details
5/15/2013Q1 2013($0.15)($0.17)$0.30 million$0.3280 millionViewListenView Earnings Details
2/20/2013Q4 2012($0.10)($0.09)ViewN/AView Earnings Details
11/12/2012Q312($0.21)($0.13)ViewN/AView Earnings Details
8/14/2012Q2 2012($0.13)ViewN/AView Earnings Details
5/15/2012Q1 2012($0.15)ViewN/AView Earnings Details
3/27/2012Q4 2011($0.42)($0.21)ViewN/AView Earnings Details
11/9/2011Q3 2011($0.49)($0.31)ViewN/AView Earnings Details
8/4/2011Q2 2011($0.45)($0.39)ViewN/AView Earnings Details
5/10/2011Q1 2011($0.44)($0.37)ViewN/AView Earnings Details
2/10/2011Q4 2010($0.39)($0.37)ViewN/AView Earnings Details
11/11/2010Q3 2010($0.36)($0.35)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Vermillion (NASDAQ:VRML) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Vermillion (NASDAQ VRML) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.67%
Institutional Ownership Percentage: 34.62%
Insider Trading History for Vermillion (NASDAQ:VRML)
Institutional Ownership by Quarter for Vermillion (NASDAQ:VRML)

Vermillion (NASDAQ VRML) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/17/2018Jack W SchulerMajor ShareholderBuy2,838,090$1.00$2,838,090.00View SEC Filing  
11/15/2017Valerie Barber PalmieriCEOBuy685$1.46$1,000.1061,963View SEC Filing  
10/16/2017Valerie Barber PalmieriInsiderBuy694$1.44$999.3661,278View SEC Filing  
9/15/2017Valerie Barber PalmieriInsiderBuy719$1.39$999.4160,584View SEC Filing  
8/23/2017Valerie Barber PalmieriInsiderBuy768$1.30$998.4059,865View SEC Filing  
5/17/2017Valerie Barber PalmieriInsiderBuy555$1.80$999.0059,097View SEC Filing  
2/17/2017Larry N FeinbergInsiderBuy617,731$1.40$864,823.40View SEC Filing  
2/13/2017Eric SchoenSVPBuy3,347$1.40$4,685.8029,872View SEC Filing  
2/13/2017Jack W SchulerMajor ShareholderBuy974,081$1.40$1,363,713.406,673,029View SEC Filing  
2/13/2017Valerie Barber PalmieriCEOBuy10,042$1.40$14,058.8058,542View SEC Filing  
2/13/2017Veronica Gh JordanDirectorBuy6,695$1.40$9,373.0070,315View SEC Filing  
1/28/2016Jack W SchulerMajor ShareholderBuy1,493$1.60$2,388.806,673,029View SEC Filing  
1/25/2016Jack W SchulerMajor ShareholderBuy3,700$1.57$5,809.006,673,029View SEC Filing  
1/21/2016Jack W SchulerMajor ShareholderBuy30,700$1.46$44,822.006,673,029View SEC Filing  
1/19/2016Jack W SchulerMajor ShareholderBuy57,749$1.45$83,736.056,673,029View SEC Filing  
1/15/2016Jack W SchulerMajor ShareholderBuy8,400$1.56$13,104.006,673,029View SEC Filing  
7/14/2015Larry N FeinbergInsiderBuy512,043$1.96$1,003,604.28View SEC Filing  
12/23/2014Jack W SchulerMajor ShareholderBuy1,288,339$1.44$1,855,208.16View SEC Filing  
12/23/2014Larry N FeinbergInsiderBuy972,222$1.44$1,399,999.68View SEC Filing  
12/19/2014Peter S RoddyDirectorBuy16,502$1.44$23,762.88View SEC Filing  
11/21/2014Valerie Barber PalmieriCOOBuy3,500$1.51$5,285.00View SEC Filing  
11/20/2014James T LafranceInsiderBuy27,907$1.44$40,186.08View SEC Filing  
11/20/2014Valerie Barber PalmieriCOOBuy30,000$1.44$43,200.00View SEC Filing  
11/19/2014James T LafranceInsiderBuy41,615$1.43$59,509.45View SEC Filing  
11/18/2014Eric SchoenCAOBuy5,000$1.42$7,100.00View SEC Filing  
11/20/2013William B CreechVPBuy2,000$2.33$4,660.00View SEC Filing  
6/11/2013William B CreechVPBuy10,000$3.18$31,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Vermillion (NASDAQ VRML) News Headlines

Source:
DateHeadline
Vermillion, Inc. (VRML) Major Shareholder Purchases $2,838,090.00 in StockVermillion, Inc. (VRML) Major Shareholder Purchases $2,838,090.00 in Stock
www.americanbankingnews.com - April 19 at 7:18 PM
Vermillion Energy to buy Spartan Energy for about C$1.4 billionVermillion Energy to buy Spartan Energy for about C$1.4 billion
www.reuters.com - April 16 at 9:33 AM
Vermillion (VRML) Prices $15 Million Public Offerings of Common Stock and Preferred StockVermillion (VRML) Prices $15 Million Public Offerings of Common Stock and Preferred Stock
www.streetinsider.com - April 13 at 4:20 PM
After-Hours Stock Movers 04/12: (DPW) (AVGO) (NWL) Higher; (VRML) (MBI) (SEAS) Lower (more...)After-Hours Stock Movers 04/12: (DPW) (AVGO) (NWL) Higher; (VRML) (MBI) (SEAS) Lower (more...)
www.streetinsider.com - April 13 at 10:05 AM
BRIEF-Vermillion Announces Pricing Of $15 Mln Concurrent Public Offerings Of StockBRIEF-Vermillion Announces Pricing Of $15 Mln Concurrent Public Offerings Of Stock
www.reuters.com - April 13 at 10:05 AM
Vermillion, Inc. Announces Proposed Concurrent Public Offerings of Common Stock and Preferred StockVermillion, Inc. Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock
globenewswire.com - April 13 at 10:05 AM
Vermillion prices equity offerings; shares down 25%Vermillion prices equity offerings; shares down 25%
seekingalpha.com - April 13 at 10:05 AM
Vermillion Inc (NASDAQ:VRML): Immense Growth Potential?Vermillion Inc (NASDAQ:VRML): Immense Growth Potential?
finance.yahoo.com - April 4 at 5:13 PM
Did Vermillion Inc’s (NASDAQ:VRML) Recent Earnings Growth Beat The Trend?Did Vermillion Inc’s (NASDAQ:VRML) Recent Earnings Growth Beat The Trend?
finance.yahoo.com - March 23 at 4:14 PM
Edited Transcript of VRML earnings conference call or presentation 13-Mar-18 8:30pm GMTEdited Transcript of VRML earnings conference call or presentation 13-Mar-18 8:30pm GMT
finance.yahoo.com - March 18 at 9:34 AM
Vermillion Reports Fourth Quarter and Fiscal Year 2017 Financial ResultsVermillion Reports Fourth Quarter and Fiscal Year 2017 Financial Results
finance.yahoo.com - March 13 at 6:09 PM
Vermillion to Present at the 30th Annual ROTH ConferenceVermillion to Present at the 30th Annual ROTH Conference
finance.yahoo.com - March 7 at 5:05 PM
Short Interest in Vermillion, Inc. (VRML) Declines By 31.3%Short Interest in Vermillion, Inc. (VRML) Declines By 31.3%
www.americanbankingnews.com - March 4 at 1:20 AM
Vermillion to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Tuesday, March 13Vermillion to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Tuesday, March 13
finance.yahoo.com - February 28 at 9:34 AM
Vermillion to Present at the 2018 BTIG Healthcare ConferenceVermillion to Present at the 2018 BTIG Healthcare Conference
finance.yahoo.com - February 23 at 9:34 AM
What Is Vermillion Inc’s (NASDAQ:VRML) Share Price Doing?What Is Vermillion Inc’s (NASDAQ:VRML) Share Price Doing?
finance.yahoo.com - February 20 at 9:13 AM
Vermillion Announces the Grant of Two Ovarian Cancer Diagnostic PatentsVermillion Announces the Grant of Two Ovarian Cancer Diagnostic Patents
finance.yahoo.com - February 13 at 9:01 AM
Vermillion (VRML) Says it was Granted of Two Ovarian Cancer Diagnostic PatentsVermillion (VRML) Says it was Granted of Two Ovarian Cancer Diagnostic Patents
www.streetinsider.com - February 6 at 9:00 AM
Will Austin lose biopharma HQ to Connecticut? It depends on who you askWill Austin lose biopharma HQ to Connecticut? It depends on who you ask
www.bizjournals.com - January 23 at 8:28 AM
Vermillion (VRML) Announces Agreement with BlueCross BlueShield of Illinois for OVA1Vermillion (VRML) Announces Agreement with BlueCross BlueShield of Illinois for OVA1
www.streetinsider.com - January 19 at 12:04 PM
Vermillion Announces Agreement with BlueCross BlueShield of IllinoisVermillion Announces Agreement with BlueCross BlueShield of Illinois
finance.yahoo.com - January 18 at 11:36 AM
Vermillion, Inc. :VRML-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018Vermillion, Inc. :VRML-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018
finance.yahoo.com - January 1 at 10:18 AM
Are Vermillion Inc’s (NASDAQ:VRML) Interest Costs Too High?Are Vermillion Inc’s (NASDAQ:VRML) Interest Costs Too High?
finance.yahoo.com - December 26 at 8:31 PM
Austin cancer-fighting company shuffles a pair of C-suite financial execsAustin cancer-fighting company shuffles a pair of C-suite financial execs
www.bizjournals.com - December 22 at 10:44 AM
Vermillion Appoints Bob Beechey to Newly Created CFO PostVermillion Appoints Bob Beechey to Newly Created CFO Post
finance.yahoo.com - December 19 at 10:34 AM
Analyzing InVitae (NVTA) & Vermillion (VRML)Analyzing InVitae (NVTA) & Vermillion (VRML)
www.americanbankingnews.com - December 17 at 5:34 PM
Short Interest in Vermillion, Inc. (VRML) Increases By 80.4%Short Interest in Vermillion, Inc. (VRML) Increases By 80.4%
www.americanbankingnews.com - December 15 at 2:04 AM
Analyzing InVitae (NVTA) and Vermillion (VRML)Analyzing InVitae (NVTA) and Vermillion (VRML)
www.americanbankingnews.com - December 12 at 11:38 PM
Reviewing Vermillion (VRML) and InVitae (NVTA)Reviewing Vermillion (VRML) and InVitae (NVTA)
www.americanbankingnews.com - December 8 at 9:08 PM
Critical Survey: Vermillion (VRML) and Digiliti Money Group (DGLT)Critical Survey: Vermillion (VRML) and Digiliti Money Group (DGLT)
www.americanbankingnews.com - December 6 at 7:46 PM
Vermillion, Inc. (VRML) Downgraded by ValuEngine to SellVermillion, Inc. (VRML) Downgraded by ValuEngine to Sell
www.americanbankingnews.com - November 25 at 6:46 AM
Vermillion to Present at the 29th Annual Piper Jaffray Healthcare ConferenceVermillion to Present at the 29th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 22 at 5:28 PM
ASPiRA Labs Announces Release of Final CMS Reimbursement Rate for OVA1ASPiRA Labs Announces Release of Final CMS Reimbursement Rate for OVA1
finance.yahoo.com - November 20 at 12:07 PM
Vermillion Announces Publication of Foundational Health Economics StudyVermillion Announces Publication of Foundational Health Economics Study
finance.yahoo.com - November 18 at 10:08 AM
Vermillion, Inc. (VRML) Issues  Earnings Results, Misses Estimates By $0.02 EPSVermillion, Inc. (VRML) Issues Earnings Results, Misses Estimates By $0.02 EPS
www.americanbankingnews.com - November 9 at 2:52 PM
Vermillion Reports Third Quarter 2017 ResultsVermillion Reports Third Quarter 2017 Results
www.bizjournals.com - November 9 at 9:38 AM
Edited Transcript of VRML earnings conference call or presentation 8-Nov-17 9:30pm GMTEdited Transcript of VRML earnings conference call or presentation 8-Nov-17 9:30pm GMT
finance.yahoo.com - November 9 at 9:38 AM
Vermillion to Present at the Canaccord Genuity 2017 Medical Technologies & Diagnostics ForumVermillion to Present at the Canaccord Genuity 2017 Medical Technologies & Diagnostics Forum
finance.yahoo.com - November 7 at 1:11 PM
Vermillion, Inc. (VRML) Price Target Raised to $2.25 at Canaccord GenuityVermillion, Inc. (VRML) Price Target Raised to $2.25 at Canaccord Genuity
www.americanbankingnews.com - November 2 at 7:42 PM
ASPiRA Labs Announces a Major Coverage Milestone - A 27% Increase in Covered Lives for OVA1ASPiRA Labs Announces a Major Coverage Milestone - A 27% Increase in Covered Lives for OVA1
finance.yahoo.com - November 1 at 10:32 AM
ASPiRA Labs Announces OVA1 Contract with Louisiana Blue Cross Blue ShieldASPiRA Labs Announces OVA1 Contract with Louisiana Blue Cross Blue Shield
finance.yahoo.com - October 31 at 11:57 AM
Vermillion to Report Third Quarter 2017 Financial Results and Host Investor Conference Call on November 8thVermillion to Report Third Quarter 2017 Financial Results and Host Investor Conference Call on November 8th
finance.yahoo.com - October 28 at 8:23 AM
ASPiRA Labs Lands Strategic Managed Care Coverage and Medicaid Licensure for OVA1®ASPiRA Labs Lands Strategic Managed Care Coverage and Medicaid Licensure for OVA1®
finance.yahoo.com - October 28 at 8:23 AM
ETFs with exposure to Vermillion, Inc. : October 2, 2017ETFs with exposure to Vermillion, Inc. : October 2, 2017
finance.yahoo.com - October 3 at 2:40 PM
ASPiRA Labs Announces In-Network Contract Agreement with HealthNet Federal Services for OVA1®ASPiRA Labs Announces In-Network Contract Agreement with HealthNet Federal Services for OVA1®
finance.yahoo.com - October 3 at 2:40 PM
Vermillion, Inc. (VRML) Sees Significant Increase in Short InterestVermillion, Inc. (VRML) Sees Significant Increase in Short Interest
www.americanbankingnews.com - September 30 at 3:50 AM
Is It Too Late To Buy Vermillion Inc (VRML)?Is It Too Late To Buy Vermillion Inc (VRML)?
finance.yahoo.com - September 23 at 10:49 AM
ETFs with exposure to Vermillion, Inc. : September 19, 2017ETFs with exposure to Vermillion, Inc. : September 19, 2017
finance.yahoo.com - September 19 at 8:30 PM
Vermillion, Inc. :VRML-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017Vermillion, Inc. :VRML-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
finance.yahoo.com - September 19 at 9:22 AM
Vermillion and ASPiRA Labs Kick Off Ovarian Cancer Awareness Month with 100,000th Patient Test Milestone and Ringing the Nasdaq Opening BellVermillion and ASPiRA Labs Kick Off Ovarian Cancer Awareness Month with 100,000th Patient Test Milestone and Ringing the Nasdaq Opening Bell
finance.yahoo.com - September 1 at 10:56 AM

SEC Filings

Vermillion (NASDAQ:VRML) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Vermillion (NASDAQ:VRML) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Vermillion (NASDAQ VRML) Stock Chart for Friday, April, 20, 2018

Loading chart…

This page was last updated on 4/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.